{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:43:12Z","timestamp":1790239392806,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170042"],"award-info":[{"award-number":["81170042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370121"],"award-info":[{"award-number":["81370121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Scientific and Technological Major Project of China","award":["2012ZX10004-901"],"award-info":[{"award-number":["2012ZX10004-901"]}]},{"name":"Doctoral Program of Higher Education of China","award":["20130181110068"],"award-info":[{"award-number":["20130181110068"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157478","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T15:08:14Z","timestamp":1465484894000},"page":"e0157478","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity"],"prefix":"10.1371","volume":"11","author":[{"given":"Shouquan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"ref1","unstructured":"World Health Organization, 2014. Global tuberculosis report 2014."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"HM Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","article-title":"Treatment of tuberculosis: guidelines","year":"2010"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"D Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2006.00941.x","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"11","author":"WW Yew","year":"2006","journal-title":"Respirology (Carlton, Vic)"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0962-8479(96)90098-2","article-title":"Liver injury during antituberculosis treatment: an 11-year study","volume":"77","author":"M Dossing","year":"1996","journal-title":"Tubercle and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.510310129","article-title":"Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection","volume":"31","author":"WM Wong","year":"2000","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"ref8","first-page":"197","article-title":"Risk factors for hepatotoxicity induced by antituberculosis drugs","volume":"47","author":"FM Devoto","year":"1997","journal-title":"Acta physiologica, pharmacologica et therapeutica latinoamericana: organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia"},{"key":"ref9","article-title":"Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity","author":"R Chen","year":"2015","journal-title":"Arch Toxicol"},{"issue":"9","key":"ref10","first-page":"994","article-title":"Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"12","author":"F Sun","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0076-6879(05)01007-4","article-title":"Disruption of the glutathione transferase pi class genes","volume":"401","author":"CJ Henderson","year":"2005","journal-title":"Methods in enzymology"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.fct.2007.06.001","article-title":"Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status","volume":"45","author":"TA Ajith","year":"2007","journal-title":"Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jep.2007.05.014","article-title":"The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[alpha]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs","volume":"112","author":"SI Gum","year":"2007","journal-title":"Journal of ethnopharmacology"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10096-013-1831-y","article-title":"GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis","volume":"32","author":"C Li","year":"2013","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"e0119481","DOI":"10.1371\/journal.pone.0119481","article-title":"Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case-Control Study","volume":"10","author":"L He","year":"2015","journal-title":"PloS one"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"G Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2014II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"C Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/cr.2009.33","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/analysis.bio-x.cn\" xlink:type=\"simple\">http:\/\/analysis.bio-x.cn<\/ext-link>)","volume":"19","author":"Z Li","year":"2009","journal-title":"Cell research"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management","volume":"3","author":"V Ramappa","year":"2013","journal-title":"Journal of clinical and experimental hepatology"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"e115410","DOI":"10.1371\/journal.pone.0115410","article-title":"Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients","volume":"9","author":"F Liu","year":"2014","journal-title":"PloS one"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"e47769","DOI":"10.1371\/journal.pone.0047769","article-title":"Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"7","author":"Y Cai","year":"2012","journal-title":"PLoS One"},{"issue":"47","key":"ref22","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"DM Townsend","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1432-1033.1994.00893.x","article-title":"Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties","volume":"224","author":"P Zimniak","year":"1994","journal-title":"Eur J Biochem"},{"issue":"23","key":"ref24","first-page":"5340","article-title":"Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene","volume":"58","author":"X Hu","year":"1998","journal-title":"Cancer research"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.clinbiochem.2011.05.024","article-title":"GSTP1 mRNA expression in human circulating blood leukocytes is associated with GSTP1 genetic polymorphism","volume":"44","author":"E Reszka","year":"2011","journal-title":"Clin Biochem"},{"issue":"4 Pt 1","key":"ref26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/jhep.2002.35534","article-title":"Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism","volume":"36","author":"A Henrion-Caude","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.7314\/APJCP.2012.13.7.3247","article-title":"Predictive role of glutathione-S-transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma","volume":"13","author":"CG Li","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3892\/mmr.2013.1435","article-title":"Genetic polymorphisms of ERCC1118, XRCC1399 and GSTP1105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatinbased adjuvant chemotherapy","volume":"7","author":"YP Liu","year":"2013","journal-title":"Molecular medicine reports"},{"issue":"49\u201350","key":"ref29","first-page":"724","article-title":"Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients","volume":"139","author":"L Jun","year":"2009","journal-title":"Swiss medical weekly"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00280-009-1046-1","article-title":"MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer","volume":"65","author":"N Sun","year":"2010","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejca.2006.09.011","article-title":"The role of glutathione-S-transferase polymorphisms in ovarian cancer survival","volume":"43","author":"CM Nagle","year":"2007","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"13","key":"ref32","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1158\/1078-0432.CCR-04-2333","article-title":"Association of GSTP1 polymorphism and survival for esophageal cancer","volume":"11","author":"JM Lee","year":"2005","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10549-007-9764-8","article-title":"Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer","volume":"111","author":"MA Bewick","year":"2008","journal-title":"Breast cancer research and treatment"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3892\/etm.2012.710","article-title":"GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients","volume":"4","author":"A Saxena","year":"2012","journal-title":"Exp Ther Med"},{"issue":"14","key":"ref35","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.3748\/wjg.v21.i14.4310","article-title":"Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients","volume":"21","author":"K Qu","year":"2015","journal-title":"World journal of gastroenterology: WJG"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","article-title":"NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy","volume":"69","author":"J Azuma","year":"2013","journal-title":"Eur J Clin Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T09:11:16Z","timestamp":1568020276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157478"}},"subtitle":[],"editor":[{"given":"Sanjai","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157478","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}